Alaunos Therapeutics, Inc.
TCRTNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for TCRT. That does not mean none is planned.
Get an email about TCRT's next catalysts
Track Alaunos Therapeutics (TCRT) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
TCRT Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
How TCRT's past catalysts played out
Market Overview
Stock performance and key metrics
doxorubicin in combination with palifosfamide-tris
Soft Tissue Sarcoma
Darinaparson
Multiple Myeloma
Indibulin
Metastatic Breast Cancer
Darinaparsin
Hematologic Neoplasms
ZIO-201
Advanced Sarcoma
INXN-2001
Melanoma
ZIO-101 (Darinaparsin)
Multiple Myeloma
Palifosfamide Tris and Doxorubicin
Soft Tissue Sarcoma
INXN-1001
Melanoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
doxorubicin in combination with palifosfamide-tris | Phase 3 | Soft Tissue Sarcoma | - | - |
Darinaparson | Phase 2 | Multiple Myeloma | - | - |
Indibulin | Phase 2 | Metastatic Breast Cancer | - | - |
Darinaparsin | Phase 2 | Hematologic Neoplasms | - | - |
ZIO-201 | Phase 2 | Advanced Sarcoma | - | - |
INXN-2001 | Phase 2 | Melanoma | - | - |
ZIO-101 (Darinaparsin) | Phase 2 | Multiple Myeloma | - | - |
Palifosfamide Tris and Doxorubicin | Phase 2 | Soft Tissue Sarcoma | - | - |
INXN-1001 | Phase 2 | Melanoma | - | - |
Frequently asked questions
What is in Alaunos Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 9 drug candidates in Alaunos Therapeutics, Inc.'s (TCRT) pipeline across Phase 3, Phase 2. Its lead program is doxorubicin in combination with palifosfamide-tris (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Alaunos Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Alaunos Therapeutics, Inc. (TCRT) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TCRT biotech catalysts?→
Add TCRT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Alaunos Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.